CCVTF yields 4.37% · JNJ yields 2.14%● Live data
📍 JNJ pulled ahead of the other in Year 6
Combined, CCVTF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CCVTF + JNJ for your $10,000?
China Conch Venture Holdings Limited, an investment holding company, provides various solutions for energy conservation and environmental protection in China, the rest of Asia, the Asia-Pacific, and South America. The company operates through Waste to Energy Project, Port Logistics Services, New Building Materials, and Investments segments. It manufactures and sells residual heat power generation, as well as offers vertical mill and related after-sales services. The company also provides port logistics services, including cargo handling, trans-shipment, and warehousing services; and alternative wall building materials, such as cellulose fiber cement sheets, and autoclaved and wood wool cement boards. In addition, it designs and constructs energy preservation and environmental protection projects; designs, sells, and installs energy preservation and environmental protection equipment; and offers construction design and engineering services. China Conch Venture Holdings Limited was incorporated in 2013 and is headquartered in Wuhu, China.
Full CCVTF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.